David D. O'Toole - 30 May 2025 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: CFO
Signature: /s/ David O'Toole
Issuer symbol: RCEL
Transactions as of: 30 May 2025
Net transactions value: +$9,186
Form type: 4
Filing time: 02 Jun 2025, 16:30:06 UTC
Previous filing: 20 Feb 2025
Next filing: 12 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
O'Toole David D	CFO	28159 AVENUE STANFORD, SUITE 220 - AVITA MEDICAL, VALENCIA	/s/ David O'Toole	02 Jun 2025	0001491140

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award	$9,186	+1,923	+7.5%	$4.78	27,657	30 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period).

Content

These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period).